Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent Developments.


Journal

Chemical record (New York, N.Y.)
ISSN: 1528-0691
Titre abrégé: Chem Rec
Pays: United States
ID NLM: 101085550

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 04 09 2020
revised: 19 10 2020
accepted: 19 10 2020
pubmed: 11 11 2020
medline: 6 7 2021
entrez: 10 11 2020
Statut: ppublish

Résumé

Herein we have reviewed our recent developments for the identification of new tacrine analogues for Alzheimer's disease (AD) therapy. Tacrine, the first cholinesterase inhibitor approved for AD treatment, did not stop the progression of AD, producing only some cognitive improvements, but exhibited secondary effects mainly due to its hepatotoxicity. Thus, the drug was withdrawn from the clinics administration. Since then, many publications have described non-hepatotoxic tacrines, and in addition, important efforts have been made to design multitarget tacrines by combining their cholinesterase inhibition profile with the modulation of other biological targets involved in AD.

Identifiants

pubmed: 33169934
doi: 10.1002/tcr.202000107
doi:

Substances chimiques

Cholinesterase Inhibitors 0
Neuroprotective Agents 0
Tacrine 4VX7YNB537
Acetylcholinesterase EC 3.1.1.7

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

162-174

Informations de copyright

© 2020 The Chemical Society of Japan & Wiley-VCH GmbH.

Références

C. Bouza, G. Martínez-Alés, T. López-Cuadrado, PLoS One 2019, 14, e0212196.
E. L. Sampson, M. R. Blanchard, L. Jones, A. Tookman, M. King, Br. J. Psychiatry 2009, 195, 61-66.
R. Guijarro, C. M. San Román, R. Gómez-Huelgas, A. Villalobos, M. Martín, M. Guil, M.-Á. Martínez-González, J. B. Toledo, Neuroepidemiology 2010, 35, 101-108.
A. Marengoni, S. Corrao, A. Nobili, M. Tettamanti, L. Pasina, F. Salerno, A. Iorio, M. Marcucci, F. Bonometti, P. M. Mannucci, Int. J. Geriatr. Psychiatry 2011, 26, 930-936.
E. Perry, R. Perry, G. Blessed, B. Tomlinson, Lancet 1977, 309, 189.
P. T. Francis, A. M. Palmer, M. Snape, G. K. Wilcock, J. Neurol. Neurosurg. Psychiatry 1999, 66, 137-147.
E. K. Perry, R. H. Perry, P. H. Gibson, G. Blessed, B. E. Tomlinson, Neurosci. Lett. 1977, 6, 85-89.
W. Velde, F. Stam, J. Am. Geriatr. Soc. 1976, 24, 12.
P. White, M. J. Goodhardt, J. P. Keet, C. R. Hiley, L. H. Carrasco, I. E. I. Williams, D. M. Bowen, Lancet 1977, 309, 668-671.
P. Davies, Lancet 1976, 308, 1403.
W. K. Summers, L. V. Majovski, G. M. Marsh, K. Tachiki, A. Kling, N. Engl. J. Med. 1986, 315, 1241-1245.
A. Haake, K. Nguyen, L. Friedman, B. Chakkamparambil, G. T. Grossberg, Expert Opin. Drug Saf. 2020, 19, 147-157.
B. Dubois, M. Chupin, H. Hampel, S. Lista, E. Cavedo, B. Croisile, G. L. Tisserand, J. Touchon, A. Bonafee, P. J. Ousset, A. A. Ameur, O. Rouaud, F. Ricolfi, A. Vighetto, F. Pasquier, C. Delmaire, M. Ceccaldi, N. Girard, C. Dufouil, S. Lehericy, I. Tonelli, F. Duveau, O. Colliot, L. Garnero, M. Sarazin, D. Dormont, Alzheimer′s Dementia 2015, 11, 1042-1049.
N. C. Inestrosa, A. Alvarez, C. A. Pérez, R. D. Moreno, M. Vicente, C. Linker, O. I. Casanueva, C. Soto, J. Garrido, Neuron 1996, 16, 881-891.
M. J. Oset-Gasque, J. Marco-Contelles, ACS Chem. Neurosci. 2018, 9, 401-403.
R. León, A. G. Garcia, J. Marco-Contelles, Med. Res. Rev. 2013, 33, 139-189.
M. Benchekroun, M. Bartolini, J. Egea, A. Romero, E. Soriano, M. Pudlo, V. Luzet, V. Andrisano, M.-L. Jimeno, M. G. López, S. Wehle, T. Gharbi, B. Refouvelet, L. de Andrés, C. Herrera-Arozamena, B. Monti, M. L. Bolognesi, M. I. Rodríguez-Franco, M. Decker, J. Marco-Contelles, L. Ismaili, ChemMedChem 2015, 10, 523-539.
M. L. Bolognesi, A. Cavalli, L. Valgimigli, M. Bartolini, M. Rosini, V. Andrisano, M. Recanatini, C. Melchiorre, J. Med. Chem. 2007, 50, 6446-6449.
A. Cavalli, M. L. Bolognesi, A. Minarini, M. Rosini, V. Tumiatti, M. Recanatini, C. Melchiorre, J. Med. Chem. 2008, 51, 347-72.
A. Romero, J. Marco-Contelles, Curr. Top. Med. Chem. 2017, 17, 3328-3335.
M. J. Oset-Gasque, J. Marco-Contelles, Curr. Top. Med. Chem. 2017, 17, 3349-3360.
C. de los Ríos, J. Marco-Contelles, Eur. J. Med. Chem. 2019, 166, 381-389.
M. Bartolini, J. Marco-Contelles, Chem. Rec. 2019, 19, 927-937.
J. Marco-Contelles, E. Pérez-Mayoral, A. Samadi, M. do C Carreiras, E. Soriano, Chem. Rev. 2009, 109, 2652-2671.
A. Samadi, C. Valderas, C. de los Ríos, A. Bastida, M. Chioua, L. González-Lafuente, I. Colmena, L. Gandía, A. Romero, L. del Barrio, M. D. Martín-de-Saavedra, M. G. López, M. Villarroya, J. Marco-Contelles, Bioorg. Med. Chem. 2011, 19, 122-133.
J. Marco-Contelles, R. León, C. de los Ríos, A. Samadi, M. Bartolini, V. Andrisano, O. Huertas, X. Barril, F. J. Luque, M. I. Rodríguez-Franco, B. López, M. G. López, A. G. García, M. do Carmo Carreiras, M. Villarroya, J. Med. Chem. 2009, 52, 2724-2732.
A. Samadi, J. Marco-Contelles, E. Soriano, M. Álvarez-Pérez, M. Chioua, A. Romero, L. González-Lafuente, L. Gandía, J. M. Roda, M. G. López, M. Villarroya, A. G. García, C. de los Ríos, Bioorg. Med. Chem. 2010, 18, 5861-5872.
O. Trott, A. J. Olson, J. Comput. Chem. 2010, 31, 455-461.
F. Denizot, R. Lang, J. Immunol. Methods 1986, 89, 271-277.
M. Chioua, E. Serrano, Y. Dgachi, H. Martin, D. Jun, J. Janockova, V. Sepsova, O. Soukup, I. Moraleda, F. Chabchoub, L. Ismaili, I. Iriepa, J. Marco-Contelles, ChemistrySelect 2018, 3, 461-466.
G. L. Ellman, K. D. Courtney, V. Andres Jr, R. M. Featherstone, Biochem. Pharmacol. 1961, 7, 88-95.
H. Lineweaver, D. Burk, J. Am. Chem. Soc. 1934, 56, 658-666.
B. Ou, M. Hampsch-Woodill, R. L. Prior, J. Agric. Food Chem. 2001, 49, 4619-4626.
A. Dávalos, C. Gómez-Cordovés, B. Bartolomé, J. Agric. Food Chem. 2004, 52, 48-54.
E. Ramos, A. Palomino-Antolín, M. Bartolini, I. Iriepa, I. Moraleda, D. Diez-Iriepa, A. Samadi, C. V. Cortina, M. Chioua, J. Egea, A. Romero, J. Marco-Contelles, Molecules 2019, 24, 1503.
J. Patocka, D. Jun, K. Kuca, Curr. Drug Metab. 2008, 9, 332-335.
C. A. Lipinski, F. Lombardo, B. W. Dominy, P. J. Feeney, Adv. Drug Delivery Rev. 1997, 23, 3-25.
H. Boulebd, L. Ismaili, H. Martin, A. Bonet, M. Chioua, J. Marco Contelles, A. Belfaitah, Future Med. Chem. 2017, 9, 723-729.
Y. Dgachi, H. Martin, R. Malek, D. Jun, J. Janockova, V. Sepsova, O. Soukup, I. Iriepa, I. Moraleda, E. Maalej, M. C. Carreiras, B. Refouvelet, F. Chabchoub, J. Marco-Contelles, L. Ismaili, J. Enzyme Inhib. Med. Chem. 2019, 34, 163-170.
D.-M. Du, P. R. Carlier, Curr. Pharm. Des. 2004, 10, 3141-3156.
D. M.-T. Camps, P. Camps, Curr. Med. Chem. 2006, 13, 399-422.
Y.-P. Pang, P. Quiram, T. Jelacic, F. Hong, S. Brimijoin, J. Biol. Chem. 1996, 271, 23646-23649.
J. E. Biggs-Houck, A. Younai, J. T. Shaw, Curr. Opin. Chem. Biol. 2010, 14, 371-382.
A. Dömling, W. Wang, K. Wang, Chem. Rev. 2012, 112, 3083-3135.
E. Ramos, J. Egea, C. de los Ríos, J. Marco-Contelles, A. Romero, Future Med. Chem. 2017, 9, 765-780.
M. Benchekroun, A. Romero, J. Egea, R. León, P. Michalska, I. Buendía, M. L. Jimeno, D. Jun, J. Janockova, V. Sepsova, O. Soukup, O. M. Bautista-Aguilera, B. Refouvelet, O. Ouari, J. Marco-Contelles, L. Ismaili, J. Med. Chem. 2016, 59, 9967-9973.
M. Rosini, V. Andrisano, M. Bartolini, M. L. Bolognesi, P. Hrelia, A. Minarini, A. Tarozzi, C. Melchiorre, J. Med. Chem. 2005, 48, 360-363.
L. Wang, I. Moraleda, I. Iriepa, A. Romero, F. López-Muñoz, M. Chioua, T. Inokuchi, M. Bartolini, J. Marco-Contelles, MedChemComm 2017, 8, 1307-1317.
M. H. M. Sharaf, P. L. Schiff Jr, A. N. Tackie, C. H. Phoebe Jr, G. E. Martin, J. Heterocycl. Chem. 1996, 33, 239-243.

Auteurs

Óscar M Bautista-Aguilera (ÓM)

Departamento de Química Orgánica and Química Inorgánica. Ctra. Madrid-Barcelona, Universidad de Alcalá, Km. 33, 6, 28871, Madrid, Spain.

Lhassane Ismaili (L)

Laboratoire de Chimie Organique et Thérapeutique, Neurosciences intégratives et cliniques EA 481, Univ. Bourgogne Franche-Comté, UFR Santé, 19, rue Ambroise Paré, F-25000, Besançon, France.

Isabel Iriepa (I)

Departamento de Química Orgánica and Química Inorgánica. Ctra. Madrid-Barcelona, Universidad de Alcalá, Km. 33, 6, 28871, Madrid, Spain.
Institute of Chemical Research Andrés M. del Río, Alcalá University, 28805-Alcalá de Henares, Madrid, Spain.

Daniel Diez-Iriepa (D)

Departamento de Química Orgánica and Química Inorgánica. Ctra. Madrid-Barcelona, Universidad de Alcalá, Km. 33, 6, 28871, Madrid, Spain.

Fakher Chabchoub (F)

Laboratoire de Chimie Appliquée: Hétérocycles, Corps Gras et Polymères, Faculté des Sciences de Sfax, Université de Sfax. B. P 802., 3000, Sfax, Tunisie.

José Marco-Contelles (J)

Laboratory of Medicinal Chemistry (IQOG, CSIC), Juan de la Cierva 3, 28006-, Madrid, Spain.

Marta Pérez (M)

Public Health Department, Faculty of Medicine and Nursing, University of the Basque Country., Leioa, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH